G2G CONSULTING

Lobbying for SHEPHERD THERAPEUTICS · rare cancer R&D

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · posted Jul 20, 2026

Lobbying activity 2

Defense

regarding funding and awareness of rare cancers

Veterans

regarding funding and awareness of rare cancers

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem